Primobolan: The Gold Standard Mild AAS — Educational Reference
Last updated: March 2026
Methenolone (Primobolan) is a DHT-derived anabolic steroid available as an injectable enanthate ester and an oral acetate form. This educational reference covers its pharmacology, enanthate vs acetate comparison, documented immune system effects from AIDS wasting studies, and counterfeit prevalence for harm reduction.
(very low androgenic activity)
Per week, intramuscular
~5 hours for oral acetate
📋 On this page
How Methenolone Works
Methenolone is a DHT derivative with a 1-methyl group and an added double bond between C1 and C2, which slows hepatic metabolism and provides mild but direct anabolic activity. It does not aromatize and has low androgenic potency.
Methenolone binds androgen receptors directly with moderate affinity. Unlike many AAS, it does not require conversion to a more potent metabolite. Its anabolic effects are modest but clean — genuine lean tissue retention rather than water-laden mass. The 1-methyl addition reduces hepatic breakdown while the DHT backbone prevents aromatization entirely.
Primobolan Enanthate (injectable) is NOT 17α-alkylated — it has minimal hepatotoxicity and a 10–14 day half-life from the enanthate ester. Primobolan Acetate (oral) IS 17α-alkylated and genuinely hepatotoxic. The injectable form is significantly safer on liver health. Oral Primobolan requires much higher doses for comparable effect and carries real liver burden.
Methenolone was studied in HIV/AIDS wasting in the late 1980s–1990s, where researchers noted preserved immune parameters alongside lean mass retention. Some data suggested beneficial effects on CD4 lymphocyte preservation, though mechanistic pathways remain unclear. This remains one of the few AAS with documented immune-adjacent data beyond simple anabolic effects.
Primobolan suppresses the hypothalamic-pituitary-testicular axis more mildly than most other AAS, particularly at lower doses. LH and FSH are reduced but endogenous testosterone doesn't drop as dramatically as with heavier androgens. Despite this, PCT with SERMs is still standard after cycles exceeding 8–10 weeks — "mild suppression" still means suppressed.
What Clinical Literature Shows
Data from published studies on methenolone — including AIDS wasting research, anabolic profiling, and pharmacological assessments of both forms.
Side Effects & Risks
Key Takeaways
- DHT derivative — cannot aromatize to estrogen under any conditions
- Anabolic:androgenic ratio ~88:44–57 — very low androgenic activity
- Injectable enanthate form has minimal hepatotoxicity (NOT 17α-alkylated)
- Oral acetate IS 17α-alkylated and carries real hepatotoxicity risk
- AIDS wasting studies show lean mass preservation and immune parameter data
- Milder HPTA suppression than most injectable AAS
- Extremely expensive and among the most counterfeited AAS worldwide
- PCT still required after extended cycles despite mild suppression profile
- Most market "Primobolan" is counterfeit — you may not be taking methenolone at all
- Immune system effects from AIDS studies not replicated in healthy subjects
- Long-term cardiovascular outcomes at bodybuilding doses (400–800mg/week) undocumented
- "Arnold's favorite" claims unverified — anecdotal celebrity attribution
- Optimal cycle length before diminishing returns vs suppression cost not established
🛒 Support & Monitoring
Even the mildest AAS requires bloodwork and monitoring. Injectable Primobolan is easier on the liver, but cardiovascular and hormonal risks remain real.
Related Resources
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
This page is for educational and harm reduction purposes only. It is not medical advice. Methenolone (Primobolan) is a Schedule III controlled substance in the United States under the Anabolic Steroid Control Act of 1990. Possession, distribution, or use without a valid prescription is illegal and carries serious legal penalties. Anabolic steroids carry significant health risks including liver damage, cardiovascular disease, and hormonal disruption. Always consult a qualified physician before making any decisions regarding hormone use. HighPeptides does not endorse or encourage the use of controlled substances.